Peter G. Kremsner
Peter G. Kremsner
Professor for Tropical Medicine, Travel Medicine and Parasitology, University of Tübingen
Verified email at
Cited by
Cited by
Allergy, parasites, and the hygiene hypothesis
M Yazdanbakhsh, PG Kremsner, R Van Ree
Science 296 (5567), 490-494, 2002
First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children
RTS, S Clinical Trials Partnership
New England Journal of Medicine 365 (20), 1863-1875, 2011
Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10
AHJ van den Biggelaar, R van Ree, LC Rodrigues, B Lell, AM Deelder, ...
The Lancet 356 (9243), 1723-1727, 2000
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S Rts
The Lancet 386 (9988), 31-45, 2015
A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants
U D'Alessandro
Artesunate combinations for treatment of malaria: meta-analysis
International Artemisinin Study Group
The Lancet 363 (9402), 9-17, 2004
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
D Ménard, N Khim, J Beghain, AA Adegnika, M Shafiul-Alam, O Amodu, ...
New England Journal of Medicine 374 (25), 2453-2464, 2016
Phase 1 trials of rVSV Ebola vaccine in Africa and Europe
ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ...
New England Journal of Medicine 374 (17), 1647-1660, 2016
Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren
AHJ van den Biggelaar, LC Rodrigues, R van Ree, JS van der Zee, ...
Journal of Infectious Diseases 189 (5), 892-900, 2004
Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma
B McCloskey, A Zumla, G Ippolito, L Blumberg, P Arbon, A Cicero, ...
The Lancet 395 (10230), 1096-1099, 2020
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial
M Adjuik, P Agnamey, A Babiker, S Borrmann, P Brasseur, M Cisse, ...
The Lancet 359 (9315), 1365-1372, 2002
Antimalarial combinations
PG Kremsner, S Krishna
The Lancet 364 (9430), 285-294, 2004
Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine
DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ...
New England Journal of Medicine 373 (21), 2025-2037, 2015
A research agenda for malaria eradication: vector control
malERA Consultative Group on Vector Control
PLoS medicine 8 (1), e1000401, 2011
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
B Mordmüller, G Surat, H Lagler, S Chakravarty, AS Ishizuka, ...
Nature 542 (7642), 445-449, 2017
Interferon-γ Responses Are Associated with Resistance to Reinfection with Plasmodium falciparum in Young African Children
AJF Luty, B Lell, R Schmidt-Ott, LG Lehman, D Luckner, B Greve, ...
The Journal of infectious diseases 179 (4), 980-988, 1999
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses
DJ Conway, DR Cavanagh, K Tanabe, C Roper, ZS Mikes, N Sakihama, ...
Nature medicine 6 (6), 689-692, 2000
Low Interleukin-12 Activity in Severe Plasmodium falciparum Malaria
AJF Luty, DJ Perkins, B Lell, R Schmidt-Ott, LG Lehman, D Luckner, ...
Infection and immunity 68 (7), 3909-3915, 2000
Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.
RTS. S Clinical Trials Partnership
PLoS medicine 11 (7), e1001685, 2014
Comparison of methods for the rapid laboratory assessment of children with malaria.
T Planche, S Krishna, M Kombila, K Engel, JF Faucher, E Ngou-Milama, ...
The American journal of tropical medicine and hygiene 65 (5), 599-602, 2001
The system can't perform the operation now. Try again later.
Articles 1–20